Biognosys

The post Affinity-Based Platforms and Unbiased Mass Spectrometry Combined for Enhanced Biomarker Discovery appeared first on Biognosys.

By Oliver Rinner, SVP of Biognosys Group The post Beyond the Numbers: Why Targeted Proteomics Matters appeared first on Biognosys.

US PTAB Revokes Sole Independent and Other Central Claims of U.S. Patent 11,435,360 PreOmics GmbH and Biognosys AG today announced a favorable outcome in an inter partes review (IPR) proceeding IPR2024-01473

The post Immunopeptidomics Data Analysis: Challenges, Advances, and Applications appeared first on Biognosys.

The post Unlocking Biological Insight with Biognosys Software: A 2025 Publication Overview appeared first on Biognosys.

The post Pushing the Limits of Proteomics with Optimized Diagonal-PASEF and Spectronaut appeared first on Biognosys.

The post How Can Library-Free directDIA Improve Immunopeptidomics with Spectronaut 20? appeared first on Biognosys.

New biocrates metabolomics/lipidomics offering enhances Biognosys' proteomics capabilities to support multiomic drug discovery and clinical/translational researchBOSTON and ZUERICH, Switzerland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Biognosys, a pioneer in n

The Challenge Carina Sihlbom Wallem's team at the Proteomics Core Facility, University of Gothenburg (Sweden)-a part of BioMS and SciLifeLab-was seeking a robust and user-friendly solution for comprehensive plasma profiling. Their objective was to impleme

The post Decoding Protein Modifications with Spectronaut: Normalizing Background Proteins for Accurate PTM Quantification appeared first on Biognosys.